Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Prince

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Neoplasia (New York, N.Y.)|November 10, 2017
Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cellsC Subramanian, K J Kovatch, M W Sim, et al.
International Journal of Immunopathology and Pharmacology|October 4, 2014
Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significanceM Athanassiou-Papaefthymiou, O Shkeir, D Kim, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Neoplasia (New York, N.Y.)|November 10, 2017
Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cellsC Subramanian, K J Kovatch, M W Sim, et al.
International Journal of Immunopathology and Pharmacology|October 4, 2014
Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significanceM Athanassiou-Papaefthymiou, O Shkeir, D Kim, et al.
Pageof 2